In a comparison of TRM-cell core signature13 gene expression scaled within donors (in columns) across both experiments, CD8+ and CD4+ CD69+ T cells from MS WM and GM lesions were highly similar to cells from MS normal-appearing or non-MS WM and GM (Figure 5D). This evidence concerns the gene CD69 and myeloid sarcoma.